Leiomyosarcoma: Immunotherapy Clinical Trials - UCLA Sarcoma Program
University of California, Los Angeles via YouTube
UC San Diego Product Management Certificate — AI-Powered PM Training
Finance Certifications Goldman Sachs & Amazon Teams Trust
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Explore immunotherapy options for treating leiomyosarcoma in this informative 34-minute video lecture by Dr. Bartosz Chmielowski from the UCLA Sarcoma Program. Gain insights into the differences between immunotherapy and other treatment approaches, understand the basics of the immune system and its responses against cancer, and learn about PDL1 inhibitors like Nivolumab. Discover ongoing clinical trials, compare the effectiveness of immunotherapy in melanoma versus sarcoma, and understand the two different goals of treatment. Delve into the safety aspects of immunotherapy and broaden your knowledge about this innovative approach to cancer treatment.
Syllabus
Introduction
Immunotherapy vs other therapies
What is immunotherapy
Immune system
Immune responses against cancer
PDL1 inhibitors
Nivolumab
Other clinical trials
Melanoma vs sarcoma
Two different goals
Is it safe
Taught by
UCLA Health